Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...
Hubbell Incorporated Declares New Share Repurchase Program
The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today approved a new share repurchase authorization of up to $500 million, set to expire in February 2028.
Top Wall Street analysts pick these 3 stocks for attractive dividends
TipRanks’ analyst ranking service spotlights three dividend-paying stocks, including International Business Machines and ...